Company Participants Conference Call Participants Good day, and thank you for standing by. Welcome to the Q1 2024 Materialise N.V. Financial Results Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Harriet Fried of LHA. Please go ahead. Thank you, everyone, for joining us today for Materialise's quarterly conference call. With us on the call are, Brigitte de Vet, Chief Executive Of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...

materialise innovators you can count on www.materialise.com NASDAQ: MTLS This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among ot ...

Materialise NV (NASDAQ:MTLS) Q4 2023 Earnings Conference Call February 21, 2024 8:30 AM ET Company Participants Harriet Fried - LHA, IR Brigitte de Vet - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Capital Markets Alexander Craeymeersch - Kepler Cheuvreux Troy Jensen - Cantor Fitzgerald Operator Good day and thank you for standing by. Welcome to Q4 2023 Materialise Financial Results Conference Call. At this time, all participants are ...

Financial Data and Key Metrics Changes - Revenue increased by 3.2% to €60.1 million compared to the third quarter of 2022, despite unfavorable market conditions [7][31] - Adjusted EBITDA grew to €7.9 million, representing an increase of almost 55% from €5.1 million last year, with an adjusted EBITDA margin of 13.1% [8][32] - Net profit for the quarter increased to €4 million or €0.07 per share, compared to €1.4 million or €0.02 per share last year [37] Business Line Data and Key Metrics Changes - The manufacturing segment revenue decreased by 4% to €25.1 million, while the software segment remained stable at €10.8 million [7][36] - The medical segment continued its double-digit growth, increasing by 13%, with software revenue growing by 10% and medical device business expanding by 15% [9][36] - Adjusted EBITDA for the medical segment amounted to €7.1 million, resulting in an improved adjusted EBITDA margin of 29.4% [9] Market Data and Key Metrics Changes - The medical segment accounted for 40% of total revenue, while manufacturing and software segments accounted for 42% and 18% respectively [34] - Deferred revenue from software licenses and maintenance fees was €40.1 million, a decrease of €2.7 million compared to the end of 2022, but an increase of €1.7 million compared to September of last year [34] Company Strategy and Development Direction - The company is focused on embracing change while preserving its core mission and values, particularly in the context of 3D printing technology [13][14] - Materialise aims to enhance its digital backbone for additive manufacturing processes, which is crucial for scaling operations [15][16] - The transition in top management is expected to provide continuity and maintain the company's strategic positioning [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate challenging macroeconomic conditions while maintaining revenue guidance for the full year between €255 million and €260 million [47] - The company anticipates that the medical device industry will recover, which could positively impact growth in software activities [64] Other Important Information - The company reported a strong balance sheet with cash reserves of €134 million and a net cash position of €67.7 million [11] - Capital expenditures for the quarter amounted to €3.9 million, including investments in a new metal printing facility in the U.S. [38] Q&A Session Summary Question: Are there any other markets showing increasing interest in the medical segment? - The software revenue is now approximately 30% nonrecurring, with the recurring part representing about 70% and gradually increasing [25] Question: What trends are being seen in the medical device market? - There is robust demand for personalized instruments and guides, but the medical device industry is cautious in its investments due to the current economic situation [64] Question: Can you provide an update on deferred revenues? - Deferred revenue has decreased in recent quarters due to timing effects, but it is expected to pick up again in the fourth quarter based on historical trends [54][55]

9 | --- | --- | --- | --- | |---------------------------|-------------------------------------------------|----------|----------| | | (in thousands of euros, except where indicated) | Q3 2023 | Q3 2022 | | Revenue | | 60,130 | 58,288 | | Cost of sales | | (26,435) | (26,245) | | Gross profit | | 33,696 | 32,042 | | | Research & development expenses | (9,476) | (9,313) | | | Sales & marketing expenses | (13,960) | (15,198) | | | General & administrative expenses | (8,640) | (8,980) | | | Other income/(expens ...

Harriet Fried - LHA, Investor Relations Peter Leys - Executive Chairman Fried Vancraen - Founder and Chief Executive Officer Koen Berges - Chief Financial Officer Johan Albrecht - Former Chief Financial Officer Operator Harriet Fried Today???s call and webcast are being accompanied by a slide presentation that reviews Materialise???s strategic, financial, and operational performance for the second quarter of 2023. To access the slides, if you haven???t already done so, please go to the Investor Relations se ...

Company Participants Operator Thank you everyone for joining us today for Materialise???s quarterly conference call. With us on the call are Fried Vancraen, Founder and Chief Executive Officer of Materialise; Peter Leys, Executive Chairman; and Johan Albrecht, Chief Financial Officer. A more detailed description of the risks and uncertainties and other factors that could impact the company???s future business or financial results can be found in the company???s most recent annual report on Form 20-F filed w ...

Q1 2023 Financial Results Conference Call April 27, 2023 This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, our ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...